- Home
- CRMT vs FBRX Comparison
CRMT vs FBRX Comparison
Compare CRMT & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRMT | FBRX |
|---|---|---|
| Founded | 1981 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.2M | 379.3M |
| IPO Year | 2026 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CRMT | FBRX |
|---|---|---|
| Price | $18.89 | $28.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $37.00 | ★ $67.00 |
| AVG Volume (30 Days) | 76.4K | ★ 180.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 147.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,390,932,000.00 | $36,000.00 |
| Revenue This Year | $2.41 | N/A |
| Revenue Next Year | $4.65 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.32 | $4.91 |
| 52 Week High | $62.55 | $35.62 |
Technical Indicators
Market Signals| Indicator | CRMT | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 34.83 | 46.34 |
| Support Level | $17.78 | $26.67 |
| Resistance Level | $28.59 | $32.12 |
| Average True Range (ATR) | 1.37 | 2.39 |
| MACD | -0.09 | -0.17 |
| Stochastic Oscillator | 27.78 | 30.31 |
Price Performance
Historical ComparisonAbout CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).